Literature DB >> 29567725

T-cell biomarkers for diagnosis of tuberculosis: candidate evaluation by a simple whole blood assay for clinical translation.

Munyaradzi Musvosvi1, Darragh Duffy2,3, Elizabeth Filander1, Hadn Africa1, Simbarashe Mabwe1, Lungisa Jaxa1, Nicole Bilek1, Alba Llibre2,3, Vincent Rouilly2,3, Mark Hatherill1, Matthew Albert2,3,4, Thomas J Scriba1,5, Elisa Nemes1,5.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29567725     DOI： 10.1183/13993003.00153-2018

Source DB:  PubMed          Journal:  Eur Respir J        ISSN： 0903-1936            Impact factor:   16.671


× No keyword cloud information.
  21 in total

Review 1.  Tuberculosis Treatment Monitoring and Outcome Measures: New Interest and New Strategies.

Authors:  Jan Heyckendorf; Sophia B Georghiou; Nicole Frahm; Norbert Heinrich; Irina Kontsevaya; Maja Reimann; David Holtzman; Marjorie Imperial; Daniela M Cirillo; Stephen H Gillespie; Morten Ruhwald
Journal:  Clin Microbiol Rev       Date:  2022-03-21       Impact factor: 50.129

2.  Phenotypic Changes on Mycobacterium Tuberculosis-Specific CD4 T Cells as Surrogate Markers for Tuberculosis Treatment Efficacy.

Authors:  Mohamed I M Ahmed; Nyanda E Ntinginya; Gibson Kibiki; Bariki A Mtafya; Hadija Semvua; Stellah Mpagama; Charles Mtabho; Elmar Saathoff; Kathrin Held; Rebecca Loose; Inge Kroidl; Mkunde Chachage; Ulrich von Both; Antelmo Haule; Anna-Maria Mekota; Martin J Boeree; Stephen H Gillespie; Michael Hoelscher; Norbert Heinrich; Christof Geldmacher
Journal:  Front Immunol       Date:  2018-09-28       Impact factor: 7.561

3.  Effect of therapy on Quantiferon-Plus response in patients with active and latent tuberculosis infection.

Authors:  Elisa Petruccioli; Teresa Chiacchio; Valentina Vanini; Gilda Cuzzi; Luigi Ruffo Codecasa; Maurizio Ferrarese; Vincenzo Schininà; Fabrizio Palmieri; Giuseppe Ippolito; Delia Goletti
Journal:  Sci Rep       Date:  2018-10-23       Impact factor: 4.379

4.  HLA-DR Marks Recently Divided Antigen-Specific Effector CD4 T Cells in Active Tuberculosis Patients.

Authors:  Rashmi Tippalagama; Akul Singhania; Paige Dubelko; Cecilia S Lindestam Arlehamn; Austin Crinklaw; Mikhail Pomaznoy; Gregory Seumois; Aruna D deSilva; Sunil Premawansa; Dhammika Vidanagama; Bandu Gunasena; N D Suraj Goonawardhana; Dinuka Ariyaratne; Thomas J Scriba; Robert H Gilman; Mayuko Saito; Randy Taplitz; Pandurangan Vijayanand; Alessandro Sette; Bjoern Peters; Julie G Burel
Journal:  J Immunol       Date:  2021-06-30       Impact factor: 5.422

5.  Combination of Blood Routine Examination and T-SPOT.TB Assay for Distinguishing Between Active Tuberculosis and Latent Tuberculosis Infection.

Authors:  Ying Luo; Guoxing Tang; Xu Yuan; Qun Lin; Liyan Mao; Huijuan Song; Ying Xue; Shiji Wu; Renren Ouyang; Hongyan Hou; Feng Wang; Ziyong Sun
Journal:  Front Cell Infect Microbiol       Date:  2021-06-29       Impact factor: 5.293

6.  Study of CD27 and CCR4 Markers on Specific CD4+ T-Cells as Immune Tools for Active and Latent Tuberculosis Management.

Authors:  Irene Latorre; Marco A Fernández-Sanmartín; Beatriz Muriel-Moreno; Raquel Villar-Hernández; Sergi Vila; Maria L De Souza-Galvão; Zoran Stojanovic; María Á Jiménez-Fuentes; Carmen Centeno; Juan Ruiz-Manzano; Joan-Pau Millet; Israel Molina-Pinargote; Yoel D González-Díaz; Alicia Lacoma; Lydia Luque-Chacón; Josefina Sabriá; Cristina Prat; Jose Domínguez
Journal:  Front Immunol       Date:  2019-01-09       Impact factor: 7.561

7.  Disease extent and anti-tubercular treatment response correlates with Mycobacterium tuberculosis-specific CD4 T-cell phenotype regardless of HIV-1 status.

Authors:  Catherine Riou; Elsa Du Bruyn; Sheena Ruzive; Rene T Goliath; Cecilia S Lindestam Arlehamn; Alessandro Sette; Alan Sher; Daniel L Barber; Robert J Wilkinson
Journal:  Clin Transl Immunology       Date:  2020-09-28

8.  Diagnostic benefits of adding EspC, EspF and Rv2348-B to the QuantiFERON Gold In-tube antigen combination.

Authors:  R Villar-Hernández; T Blauenfeldt; E García-García; B Muriel-Moreno; M L De Souza-Galvão; J P Millet; F Sabriá; A Sánchez-Montalvá; J Ruiz-Manzano; J Pilarte; M A Jiménez; C Centeno; C Martos; I Molina-Pinargote; Y D González-Díaz; J Santiago; A Cantos; I Casas; R M Guerola; C Prat; P Andersen; I Latorre; M Ruhwald; J Domínguez
Journal:  Sci Rep       Date:  2020-08-06       Impact factor: 4.379

9.  Lymphocyte-Related Immunological Indicators for Stratifying Mycobacterium tuberculosis Infection.

Authors:  Ying Luo; Ying Xue; Guoxing Tang; Yimin Cai; Xu Yuan; Qun Lin; Huijuan Song; Wei Liu; Liyan Mao; Yu Zhou; Zhongju Chen; Yaowu Zhu; Weiyong Liu; Shiji Wu; Feng Wang; Ziyong Sun
Journal:  Front Immunol       Date:  2021-06-30       Impact factor: 7.561

10.  Case-control diagnostic accuracy study of a non-sputum CD38-based TAM-TB test from a single milliliter of blood.

Authors:  Hellen Hiza; Jerry Hella; Ainhoa Arbués; Beatrice Magani; Mohamed Sasamalo; Sebastien Gagneux; Klaus Reither; Damien Portevin
Journal:  Sci Rep       Date:  2021-06-23       Impact factor: 4.379
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.